Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM242 divergent transcript (TMEM242-DT)
- Target
- TMEM242-DT
- Molecular classification
- Non-coding RNA, divergent transcript
01
Overview
TMEM242 divergent transcript (TMEM242-DT) is a non-coding RNA gene located at the *TMEM242* locus. It is transcribed in a direction opposite to that of the coding gene TMEM242 (Transmembrane protein 242)[1]. TMEM242-DT does not encode a protein and its biological function, if any, remains uncharacterized, with no described roles in disease or therapeutic applications in current biomedical databases. This distinguishes it from TMEM242, a membrane protein implicated in mitochondrial ATP synthase assembly and cellular redox modulation[2][3].
- Other names
- TMEM242-DTTMEM242 divergent transcript
02
Mechanism of action
None known; divergent non-coding transcripts generally do not have mechanisms of action associated with drug targets
03
Biological functions
Potential regulatory RNA; specific biological functions for TMEM242-DT are not characterized in the literature and databases
04
Disease associations
None specifically attributed. No direct evidence links TMEM242-DT to any disease; research is available only for protein-coding TMEM242
Beyond the preview
Go deeper on TMEM242 divergent transcript (TMEM242-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TMEM242 divergent transcript (TMEM242-DT).